Genepeutic Bio Gets Supports from Thailand Board of Investment

The Thailand Board of Investment (BOI) has approved business promotions for new projects in the field of advanced biotechnology, worth a combined 2.4 billion baht (around USD78 million) in investment, which include Genepeutic Bio, a biotech startup for advance therapeutic medical products (ATMPs) manufacturing.

Continue reading :

CEO Club 2021: Biotechnology ต่อยอดธุรกิจใน New S-Curve

THEIR OWN MEDICINE : Our Story from The Economist

Biotech entrepreneurs are building on Thailand’s robust industry ecosystem to make advanced health care more accessible.

Genepeutic Bio and NSTDA Sign an Investment Deal Agreement

This partnership strengthens the local scientific innovation start-up company and supports Thailand into a medical hub for the therapeutic applications in cell and gene immunotherapies for cancers and other potential diseases.